InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,541.12
(
0.58%
)
US TECH 100
19,723.20
(
0.42%
)
Dow Jones
39,203.05
(
-0.27%
)
Brent Oil
87.19
(
-0.17%
)
Bitcoin
55,394.98
(
-2.78%
)
Post# of 252489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bridgeofsighs post# 121683

Friday, 07/22/2011 2:07:26 PM

Friday, July 22, 2011 2:07:26 PM

Post# of 252489
Blurb from ABT 2Q11 CC re drug-eluting-stent market:

http://seekingalpha.com/article/280539-abbott-laboratories-management-discusses-q2-2011-results-earnings-call-transcript

…the thing that people forget about is international sales and markets for our overall DES portfolio make up more than 60% of our total global sales now. So we continue to see better growth in emerging markets, and PCI volume obviously in those markets is growing mid-teens versus flattish here in the U.S.

ABT will pick up share in the DES market due to JNJ’s withdrawal from the market (#msg-64256077).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up